Suppression of Proliferation of Human Glioblastoma Cells by Combined Phosphodiesterase and Multidrug Resistance-Associated Protein 1 Inhibition
The paucity of currently available therapies for glioblastoma multiforme requires novel approaches to the treatment of this brain tumour. Disrupting cyclic nucleotide-signalling through phosphodiesterase (PDE) inhibition may be a promising way of suppressing glioblastoma growth. Here, we examined th...
Main Authors: | Liliya Kopanitsa, Maksym V. Kopanitsa, Dewi Safitri, Graham Ladds, David S. Bailey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/18/9665 |
Similar Items
-
Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells
by: Vladimir Shapovalov, et al.
Published: (2021-07-01) -
Clinical Implication of Phosphodiesterase-4-Inhibition
by: Martin Alexander Schick, et al.
Published: (2022-01-01) -
A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice
by: Avelina Lee, et al.
Published: (2023-05-01) -
New Avenues for Phosphodiesterase Inhibitors in Asthma
by: Matera MG, et al.
Published: (2021-03-01) -
Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro
by: Alves Alessandra C, et al.
Published: (1997-01-01)